ArticleBioengineered2021

miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway.

Xiurong Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.